Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,116.39 +37.53 (+0.46%) Bitcoin USD
63,839.50 +961.58 (+1.53%) CMC Crypto 200
1,384.63 -11.90 (-0.85%)
Cardinal Health, Inc. (CLH.F)
| Previous close | 95.86 |
| Open | 95.90 |
| Bid | 96.84 x 20000 |
| Ask | 97.64 x 20000 |
| Day's range | 95.86 - 95.90 |
| 52-week range | 73.08 - 106.30 |
| Volume | |
| Avg. volume | 32 |
| Market cap | 23.846B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 41.04 |
| EPS (TTM) | 2.36 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 1.88 (1.96%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 57.92 |
ZacksCencora (COR) to Report Q2 Earnings: What's in the Cards?
Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
- Reuters
UPDATE 2-US FDA sends warning letter to Cardinal Health for marketing unapproved devices
The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer. The U.S. Food and Drug Administration in 2023 recommended against the use of some China-made syringes as it investigated reports of leaks, breakages and other quality problems with such products and last month expanded the guidance. Cardinal did not immediately respond to a Reuters request for comment.
ZacksAssessing Super Micro Computer (SMCI) Ahead of Q3 Earnings
Super Micro Computer's (SMCI) third-quarter fiscal 2024 performance will likely reflect strength in the Server & Storage Systems and Subsystems & Accessories segments.
